DSCD75 inhibitors are a class of chemical compounds that function by inhibiting the enzymatic activity of DSCD75, a protein implicated in various cellular pathways. The precise molecular structure of these inhibitors often incorporates specific motifs designed to interact with the active site of the DSCD75 enzyme, blocking its normal catalytic function. These inhibitors typically operate by either binding directly to the enzyme's active site or by altering its conformation in a manner that impairs substrate binding or product release. Structural characteristics of DSCD75 inhibitors often include polar functional groups that engage in hydrogen bonding or hydrophobic interactions, which stabilize their association with the enzyme. Depending on their chemical makeup, DSCD75 inhibitors can exhibit reversible or irreversible modes of inhibition, governed by the nature of the interaction with the enzyme's catalytic residues.
From a chemical perspective, the development of DSCD75 inhibitors involves fine-tuning their molecular properties, such as lipophilicity, polarity, and molecular weight, to ensure optimal interaction with the enzyme. Advanced synthetic chemistry techniques are employed to create variations of the inhibitors with different substituent groups, providing insights into structure-activity relationships. Computational methods, such as molecular docking and dynamics simulations, are often used to predict how DSCD75 inhibitors might interact with the enzyme at an atomic level. Crystallographic studies further provide detailed information on the binding mode of these inhibitors, allowing researchers to optimize chemical designs for enhanced selectivity and potency. Such studies are essential for understanding the fundamental biochemistry of DSCD75 and its role in cellular processes, providing a rich field for exploring enzymatic regulation through chemical inhibition.
SEE ALSO...
Items 1 to 10 of 17 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
Activates peroxisome proliferator-activated receptor alpha (PPARα), influencing lipid metabolism. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Inhibits gastrointestinal lipases, reducing fat absorption, and may indirectly affect lipid metabolism. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPARγ agonist, rosiglitazone modifies lipid and glucose metabolism, which could indirectly impact THEM6. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
A statin that inhibits HMG-CoA reductase, potentially affecting lipid synthesis and metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Activates PPARγ, influencing lipid metabolism and insulin sensitivity. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Lowers LDL cholesterol and triglycerides, possibly influencing lipid metabolism pathways. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Inhibits intestinal absorption of cholesterol, potentially affecting lipid homeostasis. | ||||||
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $31.00 $46.00 $122.00 $204.00 | 5 | |
Bezafibrate activates PPARs and influences lipid metabolism, potentially affecting THEM6. | ||||||
Docosa-4Z,7Z,10Z,13Z,16Z,19Z-hexaenoic Acid (22:6, n-3) | 6217-54-5 | sc-200768 sc-200768A sc-200768B sc-200768C sc-200768D | 100 mg 1 g 10 g 50 g 100 g | $94.00 $210.00 $1779.00 $8021.00 $16657.00 | 11 | |
Have roles in altering lipid profiles, which could indirectly influence lipid metabolism. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $66.00 $267.00 | 2 | |
Another PPARα activator, altering lipid profiles and potentially affecting lipid metabolism. | ||||||